McArthur K E, Wood C L, O'Dorisio M S, Zhou Z C, Gardner J D, Jensen R T
Am J Physiol. 1987 Mar;252(3 Pt 1):G404-12. doi: 10.1152/ajpgi.1987.252.3.G404.
Vasoactive intestinal peptide (VIP) receptors on guinea pig pancreatic acini differ from those on all other tissues in containing a high-affinity VIP receptor and a low-affinity VIP receptor that has a high affinity for secretin. To characterize the molecular components of these receptors, 125I-VIP was covalently cross-linked to these receptors by four different cross-linking agents: disuccinimidyl suberate, ethylene glycol bis (succinimidyl succinate), dithiobis (succinimidylpropionate), and m-maleimidobenzoyl N-hydroxysuccinimide ester. Analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis demonstrated a single major polypeptide band of Mr 45,000 and a minor polypeptide band of Mr 30,000 were cross-linked to 125I-VIP. Covalent cross-linking only occurred when a cross-linking agent was added, was inhibited by GTP, was inhibited by VIP receptor agonists or antagonists that interact with VIP receptors, and not by other pancreatic secretagogues that interact with different receptors. For inhibiting both cross-linking and binding of 125I-VIP to the major polypeptide Mr 45,000 and the minor polypeptide Mr 30,000 components, the relative potencies were VIP greater than helodermin greater than rat growth hormone releasing factor greater than peptide histidine isoleucine greater than secretin. The apparent molecular weight of the cross-linked polypeptides were unchanged by dithiothreitol. Thus the high-affinity VIP receptor on pancreatic acinar cell membranes consists of a single major polypeptide of Mr 45,000, and this polypeptide is not a subunit of a larger disulfide-linked structure. Furthermore, either the low-affinity VIP/secretin-preferring receptor was not covalently cross-linked under the experimental conditions or it consists of a major polypeptide with the same molecular weight as the high-affinity VIP receptor.
豚鼠胰腺腺泡上的血管活性肠肽(VIP)受体与所有其他组织上的不同,它含有一种高亲和力VIP受体和一种对促胰液素具有高亲和力的低亲和力VIP受体。为了表征这些受体的分子成分,用四种不同的交联剂将¹²⁵I-VIP共价交联到这些受体上:辛二酸二琥珀酰亚胺酯、乙二醇双(琥珀酰亚胺基琥珀酸酯)、二硫双(琥珀酰亚胺基丙酸酯)和间马来酰亚胺苯甲酰基N-羟基琥珀酰亚胺酯。通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳分析表明,一条分子量为45,000的主要多肽带和一条分子量为30,000的次要多肽带与¹²⁵I-VIP交联。共价交联仅在添加交联剂时发生,受GTP抑制,受与VIP受体相互作用的VIP受体激动剂或拮抗剂抑制,而不受与不同受体相互作用的其他胰腺促分泌剂抑制。为了抑制¹²⁵I-VIP与分子量为45,000的主要多肽和分子量为30,000的次要多肽成分的交联和结合,相对效力为VIP>蛙皮素>大鼠生长激素释放因子>肽组氨酸异亮氨酸>促胰液素。交联多肽的表观分子量不受二硫苏糖醇影响。因此,胰腺腺泡细胞膜上的高亲和力VIP受体由一条分子量为45,000的单一主要多肽组成,并且该多肽不是更大的二硫键连接结构的亚基。此外,在实验条件下,低亲和力VIP/促胰液素偏好受体要么没有共价交联,要么由与高亲和力VIP受体分子量相同的主要多肽组成。